Dystrophin gene Purkinje promoter DNA (DMD Dp427p promoter)

The Dystrophin gene (DMD) Dp427p promoter DNA is a tissue-specific regulatory element located at the 5' end of the DMD gene, responsible for driving the expression of the Purkinje cell-specific isoform of dystrophin (Dp427p). This promoter is primarily active in the Purkinje neurons of the cerebellum and is one of three promoters that regulate the production of full-length 427 kDa dystrophin proteins (Muntoni et al., 2003). The Dp427p isoform is essential for the stability of the dystrophin-glycoprotein complex in the central nervous system, and its absence is strongly associated with the cognitive deficits, motor learning issues, and neurodevelopmental disorders seen in patients with Duchenne muscular dystrophy (DMD) (Gorecki et al., 1992). While most current therapeutic strategies for DMD focus on restoring muscle function, the Dp427p promoter is a target of interest for addressing the neurological components of the disease. Experimental approaches like CRISPR activation (CRISPRa) aim to target this promoter to upregulate endogenous dystrophin expression in the brain (Chamberlain et al., 2017). However, therapeutic development faces significant challenges, including the need for efficient delivery across the blood-brain barrier and the risk of off-target genomic activation.

Other names

DMD P-promoterDystrophin Purkinje-specific promoterDp427p regulatory elementDMD gene promoter P

Modulation of transcriptional activity to increase expression of the endogenous Dp427p dystrophin isoform.